Creative Biolabs
Anti-Human ErbB2 Recombinant Antibody (Trastuzumab) | Creative Biolabs
Recombinant monoclonal antibody to Human ErbB2. Trastuzumab (INN; trade names Herclon, trastuzumab) is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers.
The HER receptors are proteins that are embedded in the cell membrane and communicate molecular signals from outside the cell (molecules called EGFs) to inside the cell, and turn genes on and off. The HER proteins stimulate cell proliferation. In some cancers, notably certain types of breast cancer, HER2 is over-expressed, and causes cancer cells to reproduce uncontrollably.
Supporting Documents
Data Sheet
Datasheet
MSDS
MSDS
Reviews
More Scientific Products from Creative Biolabs
-
SEP 03, 2024Microbiology Week Virtual Event Series 2024 -
SEP 18, 2024Cell Biology Virtual Event Series 2024
- See More
-
JUL 10, 2024Diagnostics and Thyroid Health
- See More
Opens in a new window
Opens an external site
Opens an external site in a new window